Keywords: pfizer, warning, bextra, adds, concerns, over, cox-2

Pfizer's warning on Bextra adds to concerns over COX-2 inhibitors

Article | 25 October 2004

Print This

US drug major Pfizer says that one of its best-selling painkillers, Bextra (valdecoxib), may increase the risk of cardiovascular events ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in